Alberta Charts Next Steps for Vaccine Eligibility, Reports 65 New Variants of COVID-19 Cases

0
51
Alberta Charts Next Steps for Vaccine Eligibility, Reports 65 New Variants of COVID-19 Cases


Once Phase 2A is completed, the province will move to Phase 2B – likely in April – which would open eligibility for adults with serious underlying illnesses.

Content of the article

Alberta outlined its plan for the next steps in vaccine eligibility, as 65 other variant COVID-19 cases were detected in the province on Monday.

Meetings for Phase 2A of the vaccine rollout in the province kicked off Monday morning, with 8,000 eligible Albertans signing up for their time slots in the early hours. Alberta Health Services reservations for eligible people will be expanded to include Albertans born 1948 or earlier and First Nations, Métis and Inuit people born 1963 or earlier at 10 a.m. on Tuesday.

Phase 2A will continue to expand until reservations are available for Albertans born between 1947 and 1956 and Aboriginal people born in 1971 or earlier. In addition, staff and residents of licensed senior support residences who did not participate in the first phase will be eligible.

More than 437,000 Albertans are eligible for Pfizer and Moderna vaccines under Phase 2A.

Publicity

This ad is not yet loaded, but your article continues below.

Content of the article

“I am very grateful to everyone who registers. I know many others are looking forward to their turns and we would ask everyone to please be patient, ”said Dr. Deena Hinshaw, Chief Medical Officer of Health for Alberta, at Monday’s press conference. .

Once Phase 2A is completed, the province will move to Phase 2B – likely in April – which would open eligibility for adults with serious underlying illnesses. Hinshaw said he carefully reviewed the list of qualifying requirements and released the full list on Monday, which is available at alberta.ca/covid19-vaccine.

The list includes chronic heart disease, vascular disease, spleen asplenia or dysfunction, diabetes, immunosuppression, pregnancy, severe mental illness, substance use disorders, blood disorders, learning and organ, bone marrow or stem cell transplants. Chronic kidney, liver, neurological and respiratory diseases were also on the list.

Each of these conditions has specific stipulations which are listed online. For example, mild or well-controlled asthma is not considered a serious underlying condition of respiratory disease.

However, people with underlying conditions will not need a note from a doctor or pharmacist to book or attend their appointment.

“We will operate under the honor system, which is the same approach taken by Ontario and other provinces,” Hinshaw said.

She encourages people to consult their doctor or pharmacist if they have questions about their eligibility or not.

Publicity

This ad is not yet loaded, but your article continues below.

Content of the article

Phase 2C is expected to launch in late April, Hinshaw said, as she has provided up-to-date information on who will be eligible at this point.

This phase includes residents and support staff of some congregational living and workplaces that are at risk of outbreaks, including correctional facilities, homeless shelters, meat packing plants, and hospitals. group homes. This includes frontline police, transportation and court sheriffs who work closely with eligible populations of congregations.

Health care workers such as pharmacists, dentists and other regulated health professionals, including students undertaking work placements in clinical fields and health care workers on First Nations reserves, will also become eligible. . And the vaccine will also be offered to caregivers of Albertans who are most at risk of serious consequences, such as designated families or caregivers of long-term care people and up to two caregivers for children under the age of 16. who have chronic illnesses but cannot. receive the vaccine themselves.

“Together, these phases represent a large group of Albertans. Over 660,000 Albertans will be eligible for Phase 2B and another 400,000 will be able to reserve in Phase 2C, ”said Hinshaw.

It will take some time to get a vaccine to everyone who wants one at these stages, Hinshaw said.

“Vaccines save lives and the benefits far outweigh the risks. I continue to encourage everyone to make an appointment to be vaccinated, ”she added.

Publicity

This ad is not yet loaded, but your article continues below.

Content of the article

“Until then, we must continue to protect each other. We must not let our guard down. ”

Alberta detects 65 cases of variants, 255 people in hospital

Alberta detected 65 more cases of variants on Monday, all of the B.1.1.7 strain which was first identified in the UK.

This brings the total of B.1.1.7 cases in the province to 967, while there have been 16 cases of the B.1.351 variant identified in South Africa and two of the P.1 strain discovered in Brazil.

Of the 985 variant cases reported to date, 474 remain active.

Alberta reported 364 new cases, which came from 6,618 tests for a positivity rate of about 5.5%. There are 4,811 active cases across the province.

The province’s R-value averaged 1.07 last week, meaning the transmission rate was on the rise.

As of Monday, there were 255 people in the hospital, including 42 in intensive care units. This is a slight increase from the 248 hospitalizations and 38 ICU admissions reported the previous day.

Three deaths from COVID-19 were reported on Monday, including a woman in the 90th of the Calgary zone, a man in his 60s from the south zone and a man in the 80th of the Edmonton zone. The provincial death toll stands at 1,949.

Alberta has now administered 368,124 doses of the COVID-19 vaccine and 91,593 people have received both vaccines.

Alberta Health Services transferred reservations for the AstraZeneca vaccine through the Health Link phone line until the supply was completely depleted. Reservations remain open for Albertans born between 1957 and 1961 and Aboriginal people between 1972 and 1976.

Publicity

This ad is not yet loaded, but your article continues below.

Content of the article

Prime Minister Justin Trudeau offered assurances on the safety of the Oxford-AstraZeneca COVID-19 vaccine on Monday as the list of European countries suspending its use due to safety concerns grew.

Germany has joined others in Europe in halting their use of the AstraZeneca vaccine due to reports of blood clots in some recipients, even though European regulators say there is no evidence the vaccine is to blame.

Health Canada’s regulators are constantly analyzing all available information about vaccines and have ensured that those approved in Canada are safe to use, Trudeau told reporters in Montreal.

With files from The Canadian Press

[email protected]
Twitter: @BabychStephanie



LEAVE A REPLY

Please enter your comment!
Please enter your name here